Paul Gallo

3.2k citations

53 papers · 1.9k indexed · 1 hit paper · h-index 22

Impact in

Statistics and Probability top 0.2%
- Statistical Methods in Clinical Trials
- Advanced Causal Inference Techniques
- Statistical Methods and Inference
Management Science and Operations Research top 2%
- Optimal Experimental Design Methods

Papers in

Statistics and Probability 43
- Statistical Methods in Clinical Trials 38
- Advanced Causal Inference Techniques 11
- Statistical Methods and Inference 8
- Statistical Methods and Bayesian Inference 5
Management Science and Operations Research 16
- Optimal Experimental Design Methods 15

Co-authors: Michael Krams Christy Chuang‐Stein Vladimir Dragalin José Cirı́aco Pinheiro Brenda Gaydos Frank Bretz Jeff Maca Masahiro Takeuchi
Journals: Drug Information Journal (10 papers)Therapeutic Innovation & Regulatory Science (8 papers)Journal of Biopharmaceutical Statistics (7 papers)Statistics in Biopharmaceutical Research (5 papers)Clinical Trials (3 papers)
Partner nations: United States Switzerland Germany

In The Last Decade

Paul Gallo

53 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis 2014 · 421 citations

Peers

Countries citing papers authored by Paul Gallo

Since Specialization

Citations

This map shows the geographic impact of Paul Gallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gallo more than expected).

Fields of papers citing papers by Paul Gallo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gallo. The network helps show where Paul Gallo may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Gallo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Gallo Line = papers co-authored together Paul Gallo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials Statistics in Biopharmaceutical Research ·Mouna Akacha, Janice Branson, Frank Bretz, Bharani Dharan, Paul Gallo, Insa Gathmann, Robert Hemmings, Julie Jones, 由寛内田, Emmanuel Zuber	2020	24
2	Lessons Learned From Multi-regional Trials With Signals of Treatment Effect Heterogeneity Therapeutic Innovation & Regulatory Science ·Gang Li, Hui Quan, Julia Rao, Fatimah Zuhra, Fei Chen, Weining Robieson, William Yang Wang, Bruce Binkowitz, Shuai Yuan, Yoko Tanaka, Josh Chen, Madison R. Wolfert, Lanju Zhang, Song Yang, Paul Gallo	2020	1
3	An additive boundary for group sequential designs with connection to conditional error Statistics in Medicine ·由寛内田, Paul Gallo	2019	3
4	On the Optimal Timing of Futility Interim Analyses Statistics in Biopharmaceutical Research ·由寛内田, Paul Gallo, David Ohlssen	2017	10
5	Addressing Challenges and Opportunities of “Less Well-Understood” Adaptive Designs Therapeutic Innovation & Regulatory Science ·Weili He, Paul Gallo, Terrence Woodsome, P Almagout, Jeff Maca, 农学冠, Xiaoyin Fan, Qi Jiang, Cunshan Wang, Min Lin	2016	6
6	DIA’s Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for “Less Well-understood” Adaptive Designs Therapeutic Innovation & Regulatory Science ·Terrence Woodsome, Paul Gallo, Weili He, Lisa A. Kammerman, Kenneth Koury, Jeff Maca, Qi Jiang, Marc K. Walton, Cunshan Wang, صادق صفارزاده, Ritsuko YAMAZOE, P Almagout	2016	7
7	Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis Journal of Clinical Oncology ·Hajime Uno, Brian Claggett, Lü Tian, Eisuke Inoue, Paul Gallo, 冀文海, Deborah Schrag, Masahiro Takeuchi, Yoshiaki Uyama, Lihui Zhao, Hicham Skali, Scott D. Solomon, Susanna Jacobus, Michael Hughes, Milton Packer, L. J. Wei Hit paper breakdown →	2014	421
8	Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials Clinical Trials ·Joshua Chen, Hao Zheng, Hui Quan, Gang Li, Paul Gallo, Fatimah Zuhra, Bruce Binkowitz, Naitee Ting, Yoko Tanaka, Xiaolong Luo, Ekopimo Ibia	2013	6
9	Adaptive Clinical Trials: Overview of Phase III Designs and Challenges Therapeutic Innovation & Regulatory Science ·Jeff Maca, Vladimir Dragalin, Paul Gallo	2013	11
10	Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive Trials Therapeutic Innovation & Regulatory Science ·Zoran Antonijevic, Paul Gallo, Christy Chuang‐Stein, Vladimir Dragalin, John W. Loewy, Sandeep Menon, Terrence Woodsome, Caroline Morgan, Matilde Sanchez	2013	9
11	A Practical Guide to Data Monitoring Committees in Adaptive Trials Therapeutic Innovation & Regulatory Science ·Taro Nakazawa, Paul Gallo, John W. Loewy, Sandeep Menon, Zoran Antonijevic, Jared Christensen, Christy Chuang‐Stein, Leena De‐Vries	2013	9
12	The future of drug development: advancing clinical trial design Nature Reviews Drug Discovery ·John J. Orloff, Frank L. Douglas, José Cirı́aco Pinheiro, Susan L. Levinson, Michael Branson, Pravin Chaturvedi, Ene Ette, Paul Gallo, Gigi Hirsch, Cyrus R. Mehta, Nitin Patel, Larysa Antoniuk, Stacy L. Springs, Donald Stanski, Matthias R. Evers, Cynthia Octavania Putri Salma, Jiang Yao-xing, 経塚雄策, Howard L. Golub	2009	110
13	Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology Statistics in Medicine ·Werner Brannath, Emmanuel Zuber, Michael Branson, Frank Bretz, Paul Gallo, Martin Posch, Dinh Van Chien	2009	131
14	What should be the role of homogeneity testing in adaptive trials? Pharmaceutical Statistics ·Paul Gallo, Christy Chuang‐Stein	2008	12
15	Operational challenges in adaptive design implementation Pharmaceutical Statistics ·Paul Gallo	2006	27
16	Adaptive Dose-Response Studies Drug Information Journal ·Brenda Gaydos, Michael Krams, Inna Perevozskaya, Frank Bretz, Frederica Roquet-Jalmar, Paul Gallo, Don Berry, B Sofiane, José Paulo Pinheiro, Alun Bedding	2006	34
17	Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults Current Medical Research and Opinion ·Edwin A. Bronsky, Jay Grossman, Milda Juknelytė, Paul Gallo, O Carballo, Giovanni Della Cioppa, John Kottakis, Sunil Mehra	2004	32
18	VALsartan In Acute Myocardial Infarction (VALIANT) Trial: Baseline Characteristics in Context European Journal of Heart Failure ·Eric J. Velazquez, Marc A. Pfeffer, John J.V. McMurray, Aldo P. Maggioni, Jean‐Lucien Rouleau, Frans Van de Werf, Lars Køber, Harvey D. White, Karl Swedberg, Jeffrey D. Leimberger, Paul Gallo, Mary Ann Sellers, Susan Edwards, Marc Henis, Robert M. Califf, (unknown)	2003	60
19	Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design American Heart Journal ·Marc A. Pfeffer, John J.V. McMurray, Alain Leizorovicz, Aldo P. Maggioni, Jean‐Lucien Rouleau, Frans Van de Werf, Marc Henis, Eric Neuhart, Paul Gallo, Susan Edwards, Mary Ann Sellers, Eric J. Velazquez, Robert M. Califf	2000	139
20	Consistency of regression estimates when some variables are subject to error Communication in Statistics- Theory and Methods ·Paul Gallo	1982	29

About Paul Gallo

Paul Gallo is a scholar working on Statistics and Probability, Management Science and Operations Research, Statistics, Probability and Uncertainty, Economics and Econometrics and Immunology, having authored 53 papers that have together received 1.9k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (38 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers), Optimal Experimental Design Methods (15 papers), Advanced Causal Inference Techniques (11 papers), Statistical Methods and Inference (8 papers), Meta-analysis and systematic reviews (6 papers), Biosimilars and Bioanalytical Methods (6 papers) and Statistical Methods and Bayesian Inference (5 papers). The work is most often cited by research in Statistics and Probability (1.1k citations), Management Science and Operations Research (380 citations), Statistics, Probability and Uncertainty (214 citations), Economics and Econometrics (489 citations) and Cardiology and Cardiovascular Medicine (264 citations). Paul Gallo has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Michael Krams, Christy Chuang‐Stein, Vladimir Dragalin, José Cirı́aco Pinheiro, Brenda Gaydos, Frank Bretz, Jeff Maca, Masahiro Takeuchi, Lihui Zhao and Hicham Skali. Their work appears in journals such as Drug Information Journal, Therapeutic Innovation & Regulatory Science, Journal of Biopharmaceutical Statistics, Statistics in Biopharmaceutical Research and Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact